Your browser doesn't support javascript.
loading
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Özgen, Heval; Spijkerman, Renske; Noack, Moritz; Holtmann, Martin; Schellekens, Arnt S A; van de Glind, Geurt; Banaschewski, Tobias; Barta, Csaba; Begeman, Alex; Casas, Miguel; Crunelle, Cleo L; Daigre Blanco, Constanza; Dalsgaard, Søren; Demetrovics, Zsolt; den Boer, Jacomine; Dom, Geert; Eapen, Valsamma; Faraone, Stephen V; Franck, Johan; González, Rafael A; Grau-López, Lara; Groenman, Annabeth P; Hemphälä, Malin; Icick, Romain; Johnson, Brian; Kaess, Michael; Kapitány-Fövény, Máté; Kasinathan, John G; Kaye, Sharlene S; Kiefer, Falk; Konstenius, Maija; Levin, Frances R; Luderer, Mathias; Martinotti, Giovanni; Matthys, Frieda I A; Meszaros, Gergely; Moggi, Franz; Munasur-Naidoo, Ashmita P; Post, Marianne; Rabinovitz, Sharon; Ramos-Quiroga, J Antoni; Sala, Regina; Shafi, Abu; Slobodin, Ortal; Staal, Wouter G; Thomasius, Rainer; Truter, Ilse; van Kernebeek, Michiel W; Velez-Pastrana, Maria C; Vollstädt-Klein, Sabine.
Afiliación
  • Özgen H; Parnassia Addiction Research Centre (PARC), Parnassia Psychiatric Institute, The Hague, The Netherlands, m.h.ozgen@parnassiagroep.nl.
  • Spijkerman R; Curium, Department of Child and Adolescent Psychiatry, Leiden University Medical Center, Leiden, The Netherlands, m.h.ozgen@parnassiagroep.nl.
  • Noack M; Parnassia Addiction Research Centre (PARC), Parnassia Psychiatric Institute, The Hague, The Netherlands.
  • Holtmann M; Department of Child and Adolescent Psychiatry, LWL-University Hospital, Ruhr-University Bochum, Hamm, Germany.
  • Schellekens ASA; Department of Child and Adolescent Psychiatry, LWL-University Hospital, Ruhr-University Bochum, Hamm, Germany.
  • van de Glind G; Department of Psychiatry, Donders institute, RadboudUMC, Nijmegen, The Netherlands.
  • Banaschewski T; Nijmegen Institute for Scientist-Practitioners in Addiction (NISPA), RadboudUMC, Nijmegen, The Netherlands.
  • Barta C; Nijmegen Institute for Scientist-Practitioners in Addiction (NISPA), RadboudUMC, Nijmegen, The Netherlands.
  • Begeman A; International Collaboration on ADHD and Substance Abuse (ICASA) Foundation, Nijmegen, The Netherlands.
  • Casas M; Department of Child and Adolescent Psychiatry, Central Institute of Mental Health Mannheim (CIMH), Heidelberg University, Mannheim, Germany.
  • Crunelle CL; Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary.
  • Daigre Blanco C; Institute of Psychology, Faculty of Humanities and Social Sciences, Pázmány Péter Catholic University, Budapest, Hungary.
  • Dalsgaard S; De Hoop GGZ, Dordrecht, The Netherlands.
  • Demetrovics Z; Department of Psychiatry and Legal Medicine, Autonomous University of Barcelona, Barcelona, Spain.
  • den Boer J; Department of Psychiatry, University Hospital Brussels, Brussels, Belgium.
  • Dom G; Department of Psychiatry, Mental Health and Addictions, Addiction and Dual Diagnosis Section, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Eapen V; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Faraone SV; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Franck J; Department of Economics and Business Economics, Aarhus University, Aarhus, Denmark.
  • González RA; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.
  • Grau-López L; De Hoop GGZ, Dordrecht, The Netherlands.
  • Groenman AP; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Antwerp, Belgium.
  • Hemphälä M; Academic Unit of Infant, Child, Adolescent Psychiatry South West Sydney, University of New South Wales, Sydney, New South Wales, Australia.
  • Icick R; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA.
  • Johnson B; Child- and Adolescent Department, Piteå Hospital, Region Norrbotten, Piteå, Sweden.
  • Kaess M; Centre for Mental Health, Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom.
  • Kapitány-Fövény M; East London NHS Foundation Trust, Child and Adolescent Mental Health Service (CAMHS) - ADHD clinic, London, United Kingdom.
  • Kasinathan JG; Department of Psychiatry, Mental Health and Addictions, Addiction and Dual Diagnosis Section, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Kaye SS; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Kiefer F; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Konstenius M; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Levin FR; Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
  • Luderer M; Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Martinotti G; Child- and Adolescent Department, Piteå Hospital, Region Norrbotten, Piteå, Sweden.
  • Matthys FIA; Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Saint-Louis - Lariboisière - Fernand Widal, Paris, France.
  • Meszaros G; INSERM U1144, Paris, France.
  • Moggi F; Inserm UMR-S1144, Université de Paris, Paris, France.
  • Munasur-Naidoo AP; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA.
  • Post M; University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Rabinovitz S; Department of Child and Adolescent Psychiatry, Center for Psychosocial Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Ramos-Quiroga JA; Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.
  • Sala R; Drug Outpatient Centre, Nyíro Gyula National Institute of Psychiatry and Addictions, Budapest, Hungary.
  • Shafi A; Adolescent Mental Health, Justice Health and Forensic Mental Health Network, Sydney, New South Wales, Australia.
  • Slobodin O; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
  • Staal WG; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany.
  • Thomasius R; Child- and Adolescent Department, Piteå Hospital, Region Norrbotten, Piteå, Sweden.
  • Truter I; Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, New York, USA.
  • van Kernebeek MW; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Frankfurt, Germany.
  • Velez-Pastrana MC; Department of Neuroscience, Imaging, Clinical Sciences, University "G.d'Annunzio", Chieti-Pescara, Chieti, Italy.
  • Vollstädt-Klein S; Department of Psychiatry, UZ Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Eur Addict Res ; 26(4-5): 223-232, 2020.
Article en En | MEDLINE | ID: mdl-32634814
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Tamizaje Masivo / Trastornos Relacionados con Sustancias / Consenso / Práctica Clínica Basada en la Evidencia Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Eur Addict Res Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Tamizaje Masivo / Trastornos Relacionados con Sustancias / Consenso / Práctica Clínica Basada en la Evidencia Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Eur Addict Res Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article